All In Biotech

Drug Trial Radar · NCT01216865

Umbilical Cord Mesenchymal Stem Cells Injection for Diabetic Foot

Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells Injection for Diabetic Foot

Last checked: Nov 20, 2026Latest source record: Oct 13, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

50

Planned (sponsor's estimate)

Start

Jan 2011

Primary completion

Dec 2012

Study completion Jul 2013

Sponsor

Lead sponsor
Qingdao UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 7, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether umbilical cord Mesenchymal Stem Cells of treatment for diabetic foot is safe and effective in the management of diabetic foot ischemia, the therapeutic effect of stem cells is caused by improving blood circulation in ischemic limb which would in turn promote ulcer healing, prevent amputation of limb and relieve the Sevier pain of ischemia.

Conditions

  • Diabetic Foot
  • Critical Limb Ischemia
  • Mesenchymal Stem Cells
  • Umbilical Cord

Interventions

  • umbilical cord mesenchymal stem cellsBiological

    5\*10/7 per ischemic limb

  • Standard TherapyDrug

    Any thing directed to improve blood perfusion in the limb example.Heparin,Antiplatelet agents etc

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Angiographic evaluation of angiogenesis at ischemic limbTime frame: 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Stem Cell Research Center of Medical School Hospital of Qingdao University

    Qingdao, Shandong, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.